欢迎来到天天文库
浏览记录
ID:54590166
大小:256.69 KB
页数:3页
时间:2020-05-02
《N末端B型利钠肽原和胱抑素C联合检测对Ⅱ型心肾综合征的诊断价值.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、第36卷第2期右江民族医学院学报Vo1.36No.22014年4月JournalofYoujiangMedicalUniversityforNationalitiesApr.2O14N末端B型利钠肽原和胱抑素C联合检测对Ⅱ型心肾综合征的诊断价值①梁继铁。郭应军(1.广东省中山市博爱医院肾内科,广东中山528403E—mail:jitie2009@163.corn;2.广东省中山市中医院重症医学科,广东中山528400)摘要:目的探讨血清N末端B型利钠肽原(NT-proBNP)和胱抑素C(Cys-c)联合检测对Ⅱ型心肾综合征(CRy)的诊断价值。方法选择238例慢性心力
2、衰竭患者,根据肾小球滤过率(GFR)水平将患者分为Ⅱ型CRS组130例(GFR<60ml/min)和单纯心力衰竭组108例(GFR>60ml/min)。分别采血检测两组NT—proBNP、Cys—C和血清肌酐(Scr)水平并进行比较分析。结果Ⅱ型CRS组血清NT—proBNP、Cys—C及Scr水平较单纯心力衰竭组明显升高(P均<0.01)。U型CRS组中,NYHA分级和肾功能分期越高,NT—proBNP、Cys~C及Scr水平也越高(NYHA分级Ⅱ级<Ⅲ级<Ⅳ级,肾功能分期I期<Ⅱ期<Ⅲ期<Ⅳ期,P均3、的生物标志物,两者联合检测对判定患者的病情严重程度及预后有重要价值。关键词:心肾综合征;N末端B型利钠肽原;胱抑素C中图分类号:R541.61;R692.5文献标识码:A文章编号:1001—5817(2014)02—0l75—03doi:10.3969/j.issn.1001—5817.2O14.02.006DiagnosticvalueofcombinedserumN—terminalprO—B—typenatriureticpeptideandcystatin-CmeasurementsintypeⅡcardiorenalsyndromeLiangJitie,Gu4、oYingjun(1.DepartmentofNephrology,BoaiHospitalofZhongshanCity,Zhongshan528403Guangdong,ChinaE—mail:jitie2009@163.corn;2.DepartmentofICU,ZhongshanHospitalofTraditionalChineseMedicine,Zhongshan528400,Guangdong,China)Abstract:ObjectiveToexplorethediagnosticvalueofmeasurementofserumN~termin5、a1pro—B—typenatriureticpeptide(NT—proBNP)combinedwithcystatin-C(Cys—C)inpatientswithtype1cardiore—nalsyndrome(CRS).MethodsAtotalof238patientswithchronicheartfailurewereassignedtoatype11CRSgroup(n一130,GFR<60ml/min)andasimpleheartfailuregroup(n一108,GFR>6Oml/min)ac—cordingtotheestimatedglo6、merularfiltrationrate(GFR).ThelevelsofserumNT—proBNP,Cys—CandScrofbothgroupsweremeasuredandcompared.ResultsThelevelsofserumNT—proBNP,Cys—CandScrinthetype1ICRSgroupweresignificantlyhigherthanthoseofthesimpleheartfailuregroup(threeP7、ionphasewere,thehigherthelevelsofser—umNT—proBNP,Cys—CandScrwere(NYHAgrade1I
3、的生物标志物,两者联合检测对判定患者的病情严重程度及预后有重要价值。关键词:心肾综合征;N末端B型利钠肽原;胱抑素C中图分类号:R541.61;R692.5文献标识码:A文章编号:1001—5817(2014)02—0l75—03doi:10.3969/j.issn.1001—5817.2O14.02.006DiagnosticvalueofcombinedserumN—terminalprO—B—typenatriureticpeptideandcystatin-CmeasurementsintypeⅡcardiorenalsyndromeLiangJitie,Gu
4、oYingjun(1.DepartmentofNephrology,BoaiHospitalofZhongshanCity,Zhongshan528403Guangdong,ChinaE—mail:jitie2009@163.corn;2.DepartmentofICU,ZhongshanHospitalofTraditionalChineseMedicine,Zhongshan528400,Guangdong,China)Abstract:ObjectiveToexplorethediagnosticvalueofmeasurementofserumN~termin
5、a1pro—B—typenatriureticpeptide(NT—proBNP)combinedwithcystatin-C(Cys—C)inpatientswithtype1cardiore—nalsyndrome(CRS).MethodsAtotalof238patientswithchronicheartfailurewereassignedtoatype11CRSgroup(n一130,GFR<60ml/min)andasimpleheartfailuregroup(n一108,GFR>6Oml/min)ac—cordingtotheestimatedglo
6、merularfiltrationrate(GFR).ThelevelsofserumNT—proBNP,Cys—CandScrofbothgroupsweremeasuredandcompared.ResultsThelevelsofserumNT—proBNP,Cys—CandScrinthetype1ICRSgroupweresignificantlyhigherthanthoseofthesimpleheartfailuregroup(threeP7、ionphasewere,thehigherthelevelsofser—umNT—proBNP,Cys—CandScrwere(NYHAgrade1I
7、ionphasewere,thehigherthelevelsofser—umNT—proBNP,Cys—CandScrwere(NYHAgrade1I
此文档下载收益归作者所有